What is NIC-ex SX1?

Stop smoking within 4 days only!

NIC-ex SX1 is a unique, safe and clinically-proven brain electric stimulation therapeutic device to treat nicotine addiction by helping you stop smoking, within days. The scientific rationale of this convenient NIC-ex SX1 anti-smoking aid is based on a centuries-old form of electric-stimulation medicine. The Chinese pioneered the application of brain electric stimulation to control chronic pain. Russian and French clinicians used brain electric stimulation to induce sleep and surgical anaesthesia, actions that were confirmed by the United States Food and Drug Administration (FDA). Electric stimulation therapy also has been reported effective in treating epilepsy, muscle spasms, nerve damage and addiction to such chemicals as opiods (heroin, morphine), alcohol and other central nervous system depressants and stimulants.
NIC-ex SX1 is a small pocket-size device that delivers a very low energy electric stimulus to the brain via electrodes placed discretely behind each ear of the user. NIC-ex SX1, designed for easy use, delivers the electric stimulus at a specific frequency established by clinical studies to have the optimum anti-nicotine, anti-smoking action. The attractive aid is worn continuously over a four-day treatment time. The user feels only the reassuringly slightest and soothing tingling sensation during the 96-hour therapy period. Because NIC-ex SX1 is convenient, user-friendly and drug-free, it is available from the manufacturer directly to you, thus eliminating the involvement of high cost medical personnel and costly price mark-ups by wholesalers and retailers.

How does NIC-ex SX1 work?

NIC-ex SX1 helps cigarette smokers stop smoking by regulating the brain levels of such natural neurochemicals as dopamine and endorphins. The neurochemical dopamine stimulates the “reward” centre in the brain resulting in a “feeling of pleasure. Endorphins, also produced naturally by the brain, are anti-stress hormone-like neurochemicals that relieve pain (anti-pain action) and enhance the immune system. The nicotine in cigarette smoke increases the brain levels of dopamine thereby giving the smoker a rewarding “feeling of pleasure”. The need of the smoker to continue getting this “feeling of pleasure” quickly results in the development of nicotine addiction. Addiction to nicotine also significantly reduces both the brain production and action of the anti-stress, anti-pain endorphins. When a smoker tries to stop smoking, the brain nicotine levels rapidly decrease, resulting in lowered levels of dopamine and an array of very unpleasant, discomforting (nicotine) withdrawal symptoms that includes an intense craving to smoke (for the nicotine irritability, insomnia, anxiety, inability to concentrate and an intense craving to smoke.

NIC-ex SX1 works by electrically stimulating the brain to produce dopamine which restores and helps sustain that “feeling of pleasure”, thus preventing the strong craving to resume smoking during nicotine withdrawal. NIC-ex SX1 also increases the brain production of the natural anti-stress, anti-pain endorphins, thereby reducing or minimizing the intensity of many of the stressful, painful nicotine withdrawal symptoms.
In summary, NIC-ex SX1 works as an effective aid in smoking cessation by efficiently regulating the appropriate brain neurochemicals that induce and maintain a “feeling of pleasure” and that reduce and even prevent many of the physical and behavioral symptoms of nicotine withdrawal during smoking cessation programs.

How successful is NIC-ex SX1?

Brain electric stimulation treatment of addiction to such chemicals as heroin, morphine, cocaine and alcohol has been published in the scientific literature. Most recently, in January, 2004, a large 6-month, double-blind controlled clinical study of NIC-ex SX1 electric stimulation therapy for smoking cessation was completed at the University Hospital, Zurich. The study concluded that NIC-ex SX1 was an effective aid in supporting the smoking cessation efforts of the study participants who wanted to stop smoking. The percentage of participants who stopped smoking and remained non-smokers was higher in the NIC-ex SX1 group during all the time periods studied compared to the control, placebo group. The NIC-ex SX1 group of participants reported less frequent and less severe withdrawal symptoms as hunger, insomnia, sadness, anxiety and, most importantly, craving for cigarettes, compared to the control group.
Thus, NIC-ex SX1 provided important withdrawal symptom relief, significantly reducing the anxiety and craving (for cigarettes) associated with stopping smoking, thereby decreasing the relapse rate (return to smoking). None of the participants experienced any side or adverse effects from the use of the NIC-ex SX1 therapeutic aid.

How safe is NIC-ex SX1?

Brain electric stimulation therapy has been shown to be a safe treatment for chemical addiction. And NIC-ex SX1, specifically, has proven to be a very safe therapeutic aid for smoking cessation programs. No side or otherwise adverse effects of any kind occurred during carefully monitored clinical studies during which NIC-ex SX1 was used as directed for the 96-hour treatment and during the subsequent observation time periods. The European Union (EU) has declared NIC-ex SX1 to be safe and in compliance with all International European Community (IEC) safety requirements. A CE Mark has been awarded to this product. Furthermore, an independent Swiss testing laboratory has verified that NIC-ex SX1 meets all of the safety requirements for such a product.